Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Summary
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
Description
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source